Literature DB >> 24101117

The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.

B Goretti1, F Patti, S Cilia, F Mattioli, C Stampatori, C Scarpazza, M P Amato, E Portaccio.   

Abstract

The Brief Repeatable Battery (BRB) of Neuropsychological Tests is one of the most widely used instruments to assess cognitive functioning in multiple sclerosis patients. However, to date, normative data for the Italian population are available only for the version A, which limits the use of the battery in longitudinal evaluations. We administered the BRB version B to 132 healthy subjects to obtain normative values taking into account the influences of demographic factors on the test scores and calculating corrections for these relevant factors (age, gender and education). Higher age and educational level were associated with better performance on all the tests. The World List Generation was also influenced by gender, since women performed better than men. Moreover, some tests of the version B seem to be easier than those of version A. Our data can improve the applicability of the BRB for both clinical and research purposes in longitudinal assessments.

Entities:  

Mesh:

Year:  2013        PMID: 24101117     DOI: 10.1007/s10072-013-1558-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

1.  Association of MRI metrics and cognitive impairment in radiologically isolated syndromes.

Authors:  M P Amato; B Hakiki; B Goretti; F Rossi; M L Stromillo; A Giorgio; M Roscio; A Ghezzi; L Guidi; M L Bartolozzi; E Portaccio; N De Stefano
Journal:  Neurology       Date:  2012-01-18       Impact factor: 9.910

2.  Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes.

Authors:  Valentina Zipoli; Benedetta Goretti; Bahia Hakiki; Gianfranco Siracusa; Sandro Sorbi; Emilio Portaccio; Maria Pia Amato
Journal:  Mult Scler       Date:  2009-12-07       Impact factor: 6.312

3.  Comparison of two brief neuropsychological batteries in people with multiple sclerosis.

Authors:  A Solari; L Mancuso; A Motta; L Mendozzi; C Serrati
Journal:  Mult Scler       Date:  2002-04       Impact factor: 6.312

4.  The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice.

Authors:  J B Boringa; R H Lazeron; I E Reuling; H J Adèr; L Pfennings; J Lindeboom; L M de Sonneville; N F Kalkers; C H Polman
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

5.  The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population.

Authors:  M P Amato; E Portaccio; B Goretti; V Zipoli; L Ricchiuti; M F De Caro; F Patti; R Vecchio; S Sorbi; M Trojano
Journal:  Mult Scler       Date:  2006-12       Impact factor: 6.312

6.  [Normalization of the Brief Repeatable Battery of Neuropsychological tests (BRB-N) for German-speaking regions. Application in relapsing-remitting and secondary progressive multiple sclerosis patients].

Authors:  P Scherer; K Baum; H Bauer; H Göhler; C Miltenburger
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

Review 7.  Cognitive changes in multiple sclerosis.

Authors:  Maria Pia Amato; Valentina Zipoli; Emilio Portaccio
Journal:  Expert Rev Neurother       Date:  2008-10       Impact factor: 4.618

8.  Benton Controlled Oral Word Association Test: reliability and updated norms.

Authors:  R M Ruff; R H Light; S B Parker; H S Levin
Journal:  Arch Clin Neuropsychol       Date:  1996       Impact factor: 2.813

9.  Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.

Authors:  Ralph H B Benedict; Maria Pia Amato; Jan Boringa; Bruno Brochet; Fred Foley; Stan Fredrikson; Paivi Hamalainen; Hans Hartung; Lauren Krupp; Iris Penner; Anthony T Reder; Dawn Langdon
Journal:  BMC Neurol       Date:  2012-07-16       Impact factor: 2.474

  9 in total
  18 in total

1.  Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study.

Authors:  Angela Federico; Stefano Tamburin; Alice Maier; Marco Faccini; Rebecca Casari; Laura Morbioli; Fabio Lugoboni
Journal:  Neurol Sci       Date:  2016-10-11       Impact factor: 3.307

2.  Assessing executive function with the D-KEFS sorting test: normative data for a sample of the Italian adult population.

Authors:  Flavia Mattioli; Chiara Stampatori; Fabio Bellomi; Cristina Scarpazza; Paola Galli; Chiara Guarneri; Barbara Corso; Cristina Montomoli; Claudia Niccolai; Benedetta Goretti; Maria Pia Amato; Elisa Riboni; Chiara Dalla Tomasina; Monica Falautano; Ruggero Capra
Journal:  Neurol Sci       Date:  2014-07-06       Impact factor: 3.307

3.  Cognitive assessment in multiple sclerosis-an Italian consensus.

Authors:  Maria Pia Amato; Vincenzo Brescia Morra; Monica Falautano; Angelo Ghezzi; Benedetta Goretti; Francesco Patti; Alice Riccardi; Flavia Mattioli
Journal:  Neurol Sci       Date:  2018-05-15       Impact factor: 3.307

4.  Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients.

Authors:  Pietro Iaffaldano; Rosa Gemma Viterbo; Maria Trojano
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

5.  Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.

Authors:  Anna M Pietroboni; Tiziana Carandini; Annalisa Colombi; Matteo Mercurio; Laura Ghezzi; Giovanni Giulietti; Marta Scarioni; Andrea Arighi; Chiara Fenoglio; Milena A De Riz; Giorgio G Fumagalli; Paola Basilico; Maria Serpente; Marco Bozzali; Elio Scarpini; Daniela Galimberti; Giorgio Marotta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-21       Impact factor: 9.236

6.  The minimal neuropsychological assessment of MS patients (MACFIMS): normative data of the Italian population.

Authors:  Paola Grossi; Emilio Portaccio; Fabio Bellomi; Valentina Bianchi; Sabina Cilia; Monica Falautano; Benedetta Goretti; Erika Pietrolongo; Rosa Gemma Viterbo; Michele Messmer Uccelli
Journal:  Neurol Sci       Date:  2020-01-17       Impact factor: 3.307

7.  Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study.

Authors:  S Bonavita; R Sacco; M Della Corte; S Esposito; M Sparaco; A d'Ambrosio; R Docimo; A Bisecco; L Lavorgna; D Corbo; S Cirillo; A Gallo; F Esposito; G Tedeschi
Journal:  J Neurol       Date:  2014-10-12       Impact factor: 4.849

8.  Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery.

Authors:  Juichi Fujimori; Ichiro Nakashima; Toru Baba; Yuko Meguro; Ryo Ogawa; Kazuo Fujihara
Journal:  eNeurologicalSci       Date:  2017-09-21

9.  Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).

Authors:  Giancarlo Comi; Francesco Patti; Maria Assunta Rocca; Flavia Caterina Mattioli; Maria Pia Amato; Paolo Gallo; Diego Centonze; Carlo Pozzilli; Francesco Saccà; Florian Then Bergh; Marta Bartezaghi; Renato Turrini; Massimo Filippi
Journal:  J Neurol       Date:  2017-10-23       Impact factor: 4.849

10.  Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Flavia Mattioli; Fabio Bellomi; Chiara Stampatori; Leandro Provinciali; Laura Compagnucci; Antonio Uccelli; Matteo Pardini; Giuseppe Santuccio; Giuditta Fregonese; Marianna Pattini; Beatrice Allegri; Raffaella Clerici; Annalisa Lattuada; Cristina Montomoli; Barbara Corso; Paolo Gallo; Alice Riccardi; Angelo Ghezzi; Marco Roscio; Maria Rosaria Tola; Chiara Calanca; Daria Baldini; Debora Trafficante; Ruggero Capra
Journal:  Front Behav Neurosci       Date:  2016-02-23       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.